Issue 2, 2008 of The Cochrane Library included 14 reviews and 14 protocols on the prevention, screening and treatment of National Health Priority Cancers.  Topics and reviews on priority cancers can be viewed below.

	Click on the title to view the full review or protocol
	Log on to The Cochrane Library to read protocols and full reviews. (click here for search tip)

	[R] Cochrane review
	[P] Protocol for Cochrane review
	[S] Summary of Cochrane review available

 Quick links to topics on this page:

• Supportive care for cancer patients 

• Psychological interventions

• Pain management

• Invasive therapies

• Physical therapies

• Radiotherapy and radioisotopes

• Complementary therapies

• Treatments for side effects of cancer treatment

• Other Cancer Reviews

Other health priority cancer topics available on this site:

• Breast cancer 

• Cancer of the cervix

• Colorectal cancer

• Lung cancer

• Melanoma and non-melanocytic skin cancer 

• Non-Hodgkins lymphoma

• Prostate cancer

 

Topic		Reviews and Protocols  Click on title to view review or protocol
Supportive care for cancer patients		Nutritional support in children with cancer undergoing chemotherapy  [P] Back to Top
Psychological interventions		Communication skills training for health care professionals working with cancer patients, their families and/or carers  [R] [s] Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients  [P] Back to Top
Pain management		Psychological therapies No reviews currently available for this topic Back to Top
		Pharmacological therapies Bisphosphonates for the relief of pain secondary to bone metastases  [R] Calcitonin for metastatic bone pain  [R] [s] Ketamine as an adjuvant to opioids for cancer pain  [R] [s] Hydromorphone for acute and chronic pain  [R] Oxycodone for cancer-related pain  [P] Oral morphine for cancer pain  [R]  [s] Methadone for cancer pain  [R] Fentanyl for chronic pain  [P] Opioids for the management of episodic pain in cancer patients  [R]  [S] Anticonvulsant drugs for acute and chronic pain  [R] Clonidine to supplement opioids for pain  [P] Opioid switching to improve pain relief and drug tolerability  [R]  [S] Neuroleptics for acute and chronic pain  [P] Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer  [R]  [S] NSAIDS or paracetamol, alone or combined with opioids, for cancer pain  [R]  [S] Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma  [R] Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction  [R] Lamotrigine for acute and chronic pain  [R] Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer  [R] Chemotherapy and/or radiotherapy after surgery for ovarian carcinosarcoma  [P] Buprenorphine for cancer pain  [P] Back to Top
Invasive therapies		Pleurodesis for malignant pleural effusions  [R] [s] Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer  [R]  [S] Back to Top
Physical therapies		Transcutaneous Electric Nerve Stimulation (TENS) for cancer pain in adults  [P] Exercise for treatment of cancer related fatigue  [P] Back to Top
Radiotherapy and radioisotopes		Radiotherapy for the palliation of painful bone metastases  [R] Back to Top
		Radioisotopes for metastatic bone pain  [R]  [s] Back to Top
Complementary therapies		Aromatherapy and massage for symptom relief in patients with cancer  [R] [s] Music for pain relief  [R]  [S] Mistletoe therapy in oncology  [R] Thymus extracts for cancer  [P] Laetrile treatment for cancer  [R]  [S] Selenium for preventing cancer  [P] Green tea (Camellia sinensis) for the prevention of cancer  [P] Music interventions for improving psychological and physical outcomes in cancer patients  [P] Dance movement therapy for improving psychological and physical outcomes in cancer patients  [P] Back to Top
Treatments for side effects of cancer treatment		Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia  [R] Amphotericin B versus fluconazole for controlling fungal infections in cancer patients with neutropenia  [R] Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia  [R]  [s] Cardioprotective interventions for patients receiving anthracyclines  [R]  [S] Colony stimulating factors for chemotherapy induced febrile neutropenia  [R]  [s] Interventions for preventing oral mucositis for patients with cancer receiving treatment  [R]  [s] Interventions for treating oral candidiasis for patients with cancer receiving treatment  [R]  [S] Interventions for psychosexual dysfunction in women treated for gynaecological malignancy  [P] Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients  [R]  [S]  Palliation of metastatic bone pain: Single fraction versus multifraction radiotherapy  [R] Physical therapies for reducing and controlling lymphoedema of the limbs  [R]  [S] Routine versus selective antifungal administration for control of fungal infection in patients with cancer  [R] Voriconazole versus amphotericin B and fluconazole in cancer patients with neutropenia  [R] Nystatin prophylaxis and treatment in severely immunodepressed patients  [R] Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients  [R] Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation  [R]  [S] Different anthracycline derivates for reducing cardiotoxicity in cancer patients  [R]  [S] Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy  [R]  [S] Comparison of clinical efficacy of serotonin receptor antagonists in highly emetogenic chemotherapy  [P] Haloperidol for treatment of nausea and vomiting in palliative care patients  [P] Low bacterial diet to prevent infection in neutropenic patients  [P] Chinese medical herbs for chemotherapy side effects in colorectal cancer patients  [R]  [S] Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients  [R]  [S] Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction  [R]  [S] Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients  [R]  [S] Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy  [R] Single-agent antibiotic therapy for the initial, empirical, treatment of febrile neutropenia- comparison of beta-lactams  [P] Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction  [P] Colony stimulating factors for afebrile neutropenia in cancer patients  [P] Anticoagulation for prolonging survival of cancer patients  [P] Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors  [P] Neurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting  [P] Anti-pseudomonal beta-lactam monotherapy for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams  [P] Interventions for sexual dysfunction following treatments for cancer  [R] Anticoagulation for the intial treatment of venous thromboembolism in patients with cancer  [R] Drug therapy for the management of cancer related fatigue  [R] Droperidol for treatment of nausea and vomiting in palliative care patients  [P] Fluid and diuretic therapy for preventing cisplatin-induced nephrotoxicity  [P] Prevention and treatment interventions for nausea and vomiting during initiation of chronic opioid therapy  [P] Psychosocial interventions for reducing fatigue during cancer treatment in adults  [P]  Urate oxidase for prevention and treatment of tumor lysis syndrome in children with cancer  [P] Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer  [R] Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases  [R] Exercise for the management of cancer-related fatigue in adults  [R] Medically assisted hydration for palliative care patients  [R] Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases  [R] Prophylactic antibiotics and G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy  [P] Back to Top
Other Cancer Reviews		Ear nose and throat cancers Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer  [P] Perioperative prophylactic antibiotics in head and neck cancer surgery  [P] Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer  [R] Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma  [R] Gynaecological Cancers Laparoscopy versus laparotomy for FIGO Stage I ovarian cancer  [P] Chemotherapy and/or radiotherapy after surgery for ovarian carcinosarcoma  [R] Topotecan for ovarian cancer  [R] Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer  [R] Adjuvant (post-surgical) chemotherapy for early stage epithelial ovarian cancer  [P] Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment  [P] Adjuvant radiotherapy for Stage I endometrial cancer  [P] Adjuvant chemotherapy for endometrial cancer  [P] Progestagens for endometrial cancer  [R] Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma  [R] Surgical interventions for early squamous cell carcinoma of the vulva  [R] Primary groin irradiation vs primary groin surgery for early vulvar cancer  [R] Adjuvant radiotherapy for all stages of vulvar cancer  [P] Neoadjuvant chemoradiation for advanced primary vulvar cancer  [R]  [S] Interventions for psychosexual dysfunction in women treated for gynaecological malignancy  [P] Adjuvant chemotherapy and/or radiotherapy after surgery for uterine carcinosarcoma  [P] Pegylated liposomal doxorubicin for relapsed ovarian cancer  [P] First line chemotherapy in low risk gestational trophoblastic neoplasia  [P] Anti-inflammatory agents for preventing the progression of cervical intraepithelial neoplasia  [P] Haematological Malignancies Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk  [R] Primary therapy for older patients with aggressive histology lymphoma  [P] High-dose cytosine arabinoside in the treatment of acute myeloid leukemia  [P] Purine Antagonists for Chronic Lymphocytic Leukaemia  [R] Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia  [R] Interventions for early stage Hodgkin's disease in children  [R] First-line double high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma  [P] Hepato-biliary Cancers Antioxidant supplements for preventing gastrointestinal cancers  [R] Transcatheter arterial embolisation and chemoembolisation for hepatocellular carcinoma  [P] Tamoxifen for hepatocellular carcinoma  [R] Interferon for hepatocellular carcinoma  [P] Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma  [R] Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma  [R] Systemic chemotherapy for inoperable hepatocellular carcinoma  [P] Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B   [R]  [S] Surgical resection for hepatocellular carcinoma  [P] Oral Cancer Screening programmes for the early detection and prevention of oral cancer  [R]  [S] Interventions for the treatment of oral cancer  [P] Renal Cancers Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer  [R]  [S] Adjuvant chemotherapy for invasive bladder cancer (individual patient data)  [R] Surgery versus radiotherapy for muscle invasive bladder cancer  [R] Neoadjuvant cisplatin for advanced bladder cancer  [R] Targeted therapy for advanced renal cell carcinoma  [R] Immunotherapy for advanced renal cell cancer  [R] Neoadjuvant chemotherapy for invasive bladder cancer  [R]  [S] Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer  [P] Laparoscopic radical cystectomy for bladder cancer  [P] Back to Top

This website is produced and maintained  by the Australasian Cochrane Centre for members of the Evidence-Based Policy Network, Australian Government Department of Health and Ageing.